The patient identifier debate
The idea of unique patient identifiers (UPIs) could very well be reality in the not-so-distant future. Despite the current standstill at the federal level, other efforts to implement UPIs are very much moving forward.
Barry Hieb, MD, chief scientist at Global Patient Identifiers, a healthcare nonprofit organization that sponsors a voluntary universal healthcare identifier system, says that's a good thing.
He points to the case of Houston's enterprise master patient index (EMPI) system, a database of some 3.5 million patients. In that database alone, there exist nearly 250,000 patients with the same first and last name and 70,000 instances where two people share first names, last names and birthdates.
"What that means is that the EMPI matching algorithm really can't do a good job because there's just a lot of uncertainty," Hieb says.
And, as Hieb has witnessed, that uncertainty can have serious consequences for patient care. First, it can lead to a false negative, which occurs when two records ought to be merged as they are on the same patient, but due to a mistype, they exist as two separate records. This, he says, could lead to the loss of certain lab test results.
What's more dangerous, he adds, are the false positives, which occur when two patient records are merged, and one patient gets treated for another patient's disease, a mistake that could prove fatal.
"The problem is that now as we're moving to regional and statewide and even national information exchange on patients, we've got to get really serious about accurate patient identification."
Hieb cites a 2008 RAND study that made the case for UPIs, concluding that identifiers are "clearly desirable for reducing errors, simplifying interoperability, increasing efficiency, improving patient confidence, promoting NHIN architectural flexibility and protecting patient privacy."
Researchers estimated the one-time cost of such system at between $1.5 billion to $11.1 billion, but could represent a total $77 billion per year in cost savings.
However, opponents of UPIs opine that the supposed clinical and financial benefits of such technology are far inferior to that of the harm they can precipitate for physician-patient trust and individual privacy rights.
Deborah Peel, MD, founder of Patient Privacy Rights, and a fierce opponent of UPIs, wrote in a Jan. 23 Wall Street Journal piece, "In the end, cutting out the patient will mean the erosion of patient trust. And the less we trust the system, the more patients will put health and life at risk to protect their privacy."
Peel pointed to the present reality of patient health information - such as genetic tests, claims data and prescription records - already being sold and commercialized. "Universal healthcare IDs would only exacerbate such practices," she wrote.
Although Hieb agrees patient privacy concerns exist with UPIs and admits these concerns need to be addressed, he argues that identifiers, if done properly, can enhance patient privacy.